Blog

What Biotechs Should Look for in a CDMO Partner Pre-Commercialization

July 9, 2025

Choosing the right CDMO partner pre-commercialization is critical for biotech success. Learn what to look for in a CDMO to ensure speed, compliance, scalability, and long-term value.

Learn More
Blog

Navigating Emerging Therapeutics: How Mikart Supports Cannabinoid and Psilocybin Drug Development

April 18, 2025

Learn how Mikart supports cannabinoid and psilocybin drug development with expert CDMO services, advanced manufacturing capabilities, and proven regulatory guidance for emerging therapeutics.

Learn More
Blog

Liquid Suspension Trends in the CDMO Space

February 21, 2025

Explore trends in liquid suspension drug formulation and learn how Mikart’s CDMO expertise and advanced manufacturing capabilities help bring high-quality liquid therapies to market.

Learn More
Blog

Accelerating Product Development with Mikart’s Non-GMP Small-Scale Laboratory

August 29, 2024

Discover how Mikart’s non-GMP small-scale laboratory accelerates product development with rapid feasibility studies, formulation optimization, and seamless scale-up to GMP manufacturing.

Learn More
Blog

Sailing Smoothly: Partnering with a CDMO for Liquid-Oral Formulation Development

April 30, 2024

Learn how partnering with a CDMO like Mikart streamlines liquid oral formulation development, from pre-formulation to commercial manufacturing and packaging solutions.

Learn More
Blog

The Crucial Role of Project Managers in Selecting a CDMO Partner

March 15, 2024

Explore the vital role project managers play in selecting a CDMO partner and how Mikart’s experienced team ensures clear communication, efficiency, and successful product outcomes.

Learn More
Blog

On the Journey to Support Drug Developers With End-to-End Outsourcing

October 10, 2023

Mikart, an oral dosage focused contract development and manufacturing organization (CDMO), is moving beyond generic manufacturing to support customers from...

Learn More
Blog

Unapproved Drugs Initiative

April 30, 2023

The Unapproved Drugs Initiative (UDI) is a program launched by the Food and Drug Administration (FDA) in 2006 to remove...

Learn More
Blog

Phase Appropriate Analytical Method Development and Validation

December 3, 2021

A critical component of the development process for investigational new drugs (INDs) is the establishment of clear, purposeful analytical methods...

Learn More
Blog

Our new website has launched

October 29, 2021

We are so pleased to announce the launch of our new website! We are excited to have launched our new...

Learn More